On or before December 1, 2020, and each December 1 thereafter, the Department shall report, in accordance with § 2–1257 of the State Government Article, to the Senate Finance Committee and the House Health and Government Operations Committee on:
(1) The number of individuals who have been screened through the Program;
(2) The types of tests used to screen those individuals;
(3) The costs of the tests; and
(4) The types of cancers detected by the tests.